The innovation imperative in biopharma is the first in a series of three reports by the Economist
Intelligence Unit. It is part of the Reinventing biopharma: Strategies for an evolving marketplace
programme, sponsored by Quintiles. The Economist Intelligence Unit conducted the survey and analysis and wrote the report. The findings and views expressed in this report do not necessarily reflect the views of the sponsor.
The author was Dr Paul Kielstra. The editors were James Watson and Rozina Ali, and Mike Kenny was responsible for layout.